المؤلفون: Luigi Cerbone, Sara Orecchia, Pietro Bertino, Sara Delfanti, Antonina Maria de Angelis, Federica Grosso

المصدر: Cancers, Vol 15, Iss 24, p 5716 (2023)

مصطلحات موضوعية: mesothelioma, target therapy, next generation sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2072-6694/15/24/5716; https://doaj.org/toc/2072-6694

URL الوصول: https://doaj.org/article/49fa430ec6454c56ad19792c02f9c400

المؤلفون: Federica Grosso, Matilde Mannucci, Francesca Ugo, Paola Ferro, Maurizio Cassinari, Antonella Vigani, Antonina Maria De Angelis, Sara Delfanti, Michela Lia, Roberto Guaschino, Stefano Barbero, Silvio Roncella, Ugo Giannoni, Marinella Bertolotti, Maria Pia Pistillo, Vincenzo Fontana

المصدر: Diagnostics, Vol 11, Iss 11, p 2015 (2021)

مصطلحات موضوعية: mesothelioma, mesothelin, serum biomarkers, modified RECIST, longitudinal study, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2075-4418/11/11/2015; https://doaj.org/toc/2075-4418

URL الوصول: https://doaj.org/article/28405c6350474f358c3d863dfe112cdc

المؤلفون: Caterina Viscomi, Pierosandro Tagliaferri, Nicoletta Staropoli, Pierfrancesco Tassone, Cirino Botta, Simona Gualtieri, Domenico Ciliberto, Antonina Maria De Angelis, Lucia Fiorillo, Angela Salvino

المساهمون: Staropoli, Nicoletta, Botta, Cirino, Ciliberto, Domenico, Fiorillo, Lucia, Angelis, Antonina Maria De, Viscomi, Caterina, Gualtieri, Simona, Salvino, Angela, Tassone, Pierfrancesco, Tagliaferri, Pierosandro

المصدر: Journal of Cancer Therapy. :1005-1017

مصطلحات موضوعية: Gynecology, Oncology, medicine.medical_specialty, endocrine system diseases, Bevacizumab, target therapy, business.industry, medicine.medical_treatment, Gold standard, bevacizumab, medicine.disease, Malignancy, Carboplatin, chemistry.chemical_compound, ovarian cancer, Paclitaxel, chemistry, Internal medicine, medicine, platinum, business, Ovarian cancer, Pathological, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98390c1dd6d9950084334f8ccbc286aa
https://doi.org/10.4236/jct.2013.45115

المؤلفون: F. Caglioti, Lucia Fiorillo, Francesco Mendicino, Pierosandro Tagliaferri, Cirino Botta, Domenico Ciliberto, Pierfrancesco Tassone, Nicoletta Staropoli, Silvia Chiellino, Simona Gualtieri, Antonina Maria De Angelis, Michele Caraglia

المساهمون: Ciliberto D., Staropoli N., Caglioti F., Gualtieri S., Fiorillo L., Chiellino S., De Angelis A.M., Mendicino F., Botta C., Caraglia M., Tassone P., Tagliaferri P., Ciliberto, Domenico, Staropoli, Nicoletta, Caglioti, Francesca, Gualtieri, Simona, Fiorillo, Lucia, Chiellino, Silvia, De Angelis, Antonina Maria, Mendicino, Francesco, Botta, Cirino, Caraglia, Michele, Tassone, Pierfrancesco, Tagliaferri, Pierosandro

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Angiogenesis Inhibitors, Bioinformatics, Targeted therapy, law.invention, Randomized controlled trial, Targeted pathway, Stomach Neoplasm, law, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Meta-analysi, Molecular Targeted Therapy, Systemic chemotherapy, Survival analysis, Randomized Controlled Trials as Topic, Pharmacology, Antineoplastic Combined Chemotherapy Protocol, business.industry, Cancer, Advanced gastric cancer, medicine.disease, Survival Analysis, ErbB Receptors, Angiogenesi, Pooled analysis, Tolerability, Meta-analysis, Clinical Study, Molecular Medicine, Receptor, Epidermal Growth Factor, Survival Analysi, Randomized clinical trial, business, Gastric cancer, Angiogenesis Inhibitor, Human

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668fa7309d7aaad4ea75fa8111f7d541
https://europepmc.org/articles/PMC4623405/